Lesion Absorbed Dose-Response Relationship in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy.
Saved in:
| Title: | Lesion Absorbed Dose-Response Relationship in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy. |
|---|---|
| Authors: | Grkovski M; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York; grkovskm@mskcc.org schoderh@mskcc.org., Krebs SS; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Nuclear Medicine, Division of Diagnostic Imaging, University of Texas M.D. Anderson Cancer Center, Houston, Texas., O'Donoghue JA; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York., Kuten J; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Mauguen A; Department of Epidemiology-Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York; and., Shobeiri P; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Lafontaine D; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York., Thor M; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York., Augensen F; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York., Fox JJ; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Pandit-Taskar N; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.; Nuclear Medicine Division, Department of Radiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania., Dunphy MP; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Bodei L; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Humm JL; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York., Schöder H; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; grkovskm@mskcc.org schoderh@mskcc.org. |
| Source: | Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2025 Oct 01; Vol. 66 (10), pp. 1622-1630. Date of Electronic Publication: 2025 Oct 01. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40774698 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Lesion Absorbed Dose-Response Relationship in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [<superscript>177</superscript>Lu]Lu-PSMA-617 Radiopharmaceutical Therapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Grkovski+M%22">Grkovski M</searchLink>; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York; grkovskm@mskcc.org schoderh@mskcc.org.<br /><searchLink fieldCode="AU" term="%22Krebs+SS%22">Krebs SS</searchLink>; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Nuclear Medicine, Division of Diagnostic Imaging, University of Texas M.D. Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22O'Donoghue+JA%22">O'Donoghue JA</searchLink>; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Kuten+J%22">Kuten J</searchLink>; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Mauguen+A%22">Mauguen A</searchLink>; Department of Epidemiology-Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York; and.<br /><searchLink fieldCode="AU" term="%22Shobeiri+P%22">Shobeiri P</searchLink>; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Lafontaine+D%22">Lafontaine D</searchLink>; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Thor+M%22">Thor M</searchLink>; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Augensen+F%22">Augensen F</searchLink>; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Fox+JJ%22">Fox JJ</searchLink>; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Pandit-Taskar+N%22">Pandit-Taskar N</searchLink>; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.; Nuclear Medicine Division, Department of Radiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Dunphy+MP%22">Dunphy MP</searchLink>; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Bodei+L%22">Bodei L</searchLink>; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Humm+JL%22">Humm JL</searchLink>; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Schöder+H%22">Schöder H</searchLink>; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; grkovskm@mskcc.org schoderh@mskcc.org. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220217410%22">Journal of nuclear medicine : official publication, Society of Nuclear Medicine</searchLink> [J Nucl Med] 2025 Oct 01; Vol. 66 (10), pp. 1622-1630. <i>Date of Electronic Publication: </i>2025 Oct 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Society+of+Nuclear+Medicine%22">Society of Nuclear Medicine </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0217410 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1535-5667 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201615505%22">01615505 </searchLink><i>NLM ISO Abbreviation: </i>J Nucl Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40774698 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.2967/jnumed.125.270170 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1622 Titles: – TitleFull: Lesion Absorbed Dose-Response Relationship in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Grkovski M – PersonEntity: Name: NameFull: Krebs SS – PersonEntity: Name: NameFull: O'Donoghue JA – PersonEntity: Name: NameFull: Kuten J – PersonEntity: Name: NameFull: Mauguen A – PersonEntity: Name: NameFull: Shobeiri P – PersonEntity: Name: NameFull: Lafontaine D – PersonEntity: Name: NameFull: Thor M – PersonEntity: Name: NameFull: Augensen F – PersonEntity: Name: NameFull: Fox JJ – PersonEntity: Name: NameFull: Pandit-Taskar N – PersonEntity: Name: NameFull: Dunphy MP – PersonEntity: Name: NameFull: Bodei L – PersonEntity: Name: NameFull: Humm JL – PersonEntity: Name: NameFull: Schöder H IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2025 Oct 01 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1535-5667 Numbering: – Type: volume Value: 66 – Type: issue Value: 10 Titles: – TitleFull: Journal of nuclear medicine : official publication, Society of Nuclear Medicine Type: main |
| ResultId | 1 |
